Found: 24
Select item for more details and to access through your institution.
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 5, p. 1, doi. 10.1002/prp2.649
- By:
- Publication type:
- Article
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01089-5
- By:
- Publication type:
- Article
Richter transformation driven by Epstein–Barr virus reactivation during therapy‐related immunosuppression in chronic lymphocytic leukaemia.
- Published in:
- Journal of Pathology, 2018, v. 245, n. 1, p. 61, doi. 10.1002/path.5060
- By:
- Publication type:
- Article
Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 776, doi. 10.1111/bjh.18912
- By:
- Publication type:
- Article
Maintenance therapy with ex vivo expanded lymphokine‐activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1064, doi. 10.1111/bjh.16474
- By:
- Publication type:
- Article
Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 5, p. 661, doi. 10.1111/bjh.16227
- By:
- Publication type:
- Article
Intensification treatment based on early FDG- PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 327, doi. 10.1111/bjh.13036
- By:
- Publication type:
- Article
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1023, doi. 10.1007/s00277-020-04056-9
- By:
- Publication type:
- Article
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 11, p. 1879, doi. 10.1007/s00277-014-2135-8
- By:
- Publication type:
- Article
Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 18, p. 1292, doi. 10.1093/jnci/djj358
- By:
- Publication type:
- Article
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 1, p. 38, doi. 10.1111/ejh.12782
- By:
- Publication type:
- Article
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 321, doi. 10.1111/j.1600-0609.2010.01478.x
- By:
- Publication type:
- Article
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.
- Published in:
- Nature Communications, 2016, v. 7, n. 6, p. 11889, doi. 10.1038/ncomms11889
- By:
- Publication type:
- Article
Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S316, doi. 10.1016/j.clml.2019.07.291
- By:
- Publication type:
- Article
Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Splenic marginal zone lymphoma with Evans' syndrome, autoimmunity, and peripheral gamma/delta T cells.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.
- Published in:
- Immunologic Research, 2016, v. 64, n. 2, p. 548, doi. 10.1007/s12026-015-8747-9
- By:
- Publication type:
- Article
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00594-1
- By:
- Publication type:
- Article
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
- Published in:
- Genes, Chromosomes & Cancer, 2002, v. 35, n. 1, p. 11, doi. 10.1002/gcc.10090
- By:
- Publication type:
- Article
Efficacy and Safety of Liposomal Cytarabine in Lymphoma Patients With Central Nervous System Involvement From Lymphoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 9, p. 1892, doi. 10.1002/cncr.24204
- By:
- Publication type:
- Article
ACQUIRED INHIBITOR OF THE INTRINSIC PATHWAY IN A NON-HAEMOPHILIC PATIENT. CONTROL OF BLEEDING BY RECOMBINANT FACTOR VIIa.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 1, p. 284, doi. 10.1046/j.1365-2141.2002.380712.x
- By:
- Publication type:
- Article
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 103, n. 3, p. 603, doi. 10.1007/s11060-010-0428-x
- By:
- Publication type:
- Article
Long-Term Survival in Primary Plasma Cell Leukemia after Therapy with VAD, Autologous Blood Stem Cell Transplantation and Interferon-Alpha.
- Published in:
- Acta Haematologica, 1999, v. 101, n. 4, p. 193, doi. 10.1159/000040952
- By:
- Publication type:
- Article